Article Details

B.Riley Financial Initiates a Buy Rating on Inmune Bio (INMB)

Retrieved on: 2021-04-21 06:51:39

Tags for this article:

Click the tags to see associated articles and topics

B.Riley Financial Initiates a Buy Rating on Inmune Bio (INMB). View article details on hiswai:

Excerpt

Inmune Bio, Inc. is a clinical stage biotechnology company, which develops immunotherapies that reprogram a patient's innate immune system to ...

Article found on: www.analystratings.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up